Lipid nanoparticle (LNP)-based drug delivery systems (DDSs) are widely recognized for their ability to enhance efficient and precise delivery of therapeutic agents. including nucleic acids like DNA and mRNA. Despite this acknowledgment. there is a notable knowledge gap regarding the systemic biodistribution and organ accumulation of these nanoparticles. https://www.plataformalabcc.com/product-category/shorts/